v3.26.3
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:    
Research and development $ 53,798 $ 61,527
General and administrative 29,168 18,367
Total operating expenses 82,966 79,894
Operating loss (82,966) (79,894)
Non-operating income:    
Interest and other income, net 5,380 5,482
Net loss (77,586) (74,412)
Other comprehensive income (loss):    
Net unrealized gain (loss) on marketable debt securities (112) 72
Comprehensive loss $ (77,698) $ (74,340)
Net loss per common share - basic (in dollars per share) $ (0.75) $ (0.98)
Net loss per common share - diluted (in dollars per share) $ (0.75) $ (0.98)
Weighted average shares outstanding - basic (in shares) 103,907,114 75,999,290
Weighted average shares outstanding - diluted (in shares) 103,907,114 75,999,290